Boehringer to invest a further $19M in German plant expansion

Boehringer's production facilities in Dortmund, Germany--Courtesy of Boehringer Ingelheim

Boehringer Ingelheim has added a subproject to the expansion of its Respimat production plant in Dortmund, Germany. The subproject began last year and accounts for the €15 million ($19 million) increase in the estimated cost of the expansion since Boehringer first revealed its plans in 2012. "Recalculations of investments are not unusual in a project of this size and duration," a spokesperson told FiercePharmaManufacturing. Release